Page last updated: 2024-11-01

nortriptyline and Malignant Melanoma

nortriptyline has been researched along with Malignant Melanoma in 2 studies

Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuzu, OF1
Gowda, R1
Noory, MA1
Robertson, GP1
Parker, KA1
Glaysher, S1
Hurren, J1
Knight, LA1
McCormick, D1
Suovouri, A1
Amberger-Murphy, V1
Pilkington, GJ1
Cree, IA1

Other Studies

2 other studies available for nortriptyline and Malignant Melanoma

ArticleYear
Modulating cancer cell survival by targeting intracellular cholesterol transport.
    British journal of cancer, 2017, Aug-08, Volume: 117, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Animals; Antidepressive Agents, Tricyclic; Antips

2017
The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures.
    Anti-cancer drugs, 2012, Volume: 23, Issue:1

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Cell Line, Tumor; Clomipramine; Dose-Response Relat

2012